Outcome | Measurement | T0 | T1 | T2 | T3 | T6 |
---|---|---|---|---|---|---|
Interview (i) Self-report (s) | Baseline | Session 4 | Session 8 | Posttreatment | Follow-up | |
Social participation | Experience Sampling Method (s) | x | Â | Â | x | x |
Paranoia | GPTS (s) | x | x | x | x | x |
Interaction anxiety | SIAS (s) | x | x | x | x | x |
Depression | BDI-II (s) | x | Â | Â | x | x |
Stigma | ISMI (s) | x | Â | Â | x | x |
Schemas | BCSS (s) | x | Â | Â | x | x |
Safety behavior | SBQ (i) | x | Â | Â | x | x |
Cognitive biases | DACOBS (s) | x | Â | Â | x | x |
Social functioning | SOFAS (i) | x | Â | Â | x | x |
Quality of life | MANSA (i) | x | Â | Â | x | x |
Cost-effectiveness | TIC-P (i) | x | Â | Â | x | x |
Cyber sickness | SSQ (s) | Â | x | x | Â | Â |
Presence | IPQ (s) | Â | x | x | Â | Â |
Medication adherence | BARS (i) | x | x | x | x | x |